Product Details:
Payment & Shipping Terms:
|
Alias: | SR 9009 | CAS: | 1379686-30-2 |
---|---|---|---|
Assay: | 99% | Apperance: | White Powder |
Package: | Discreet Ways Of Packing For Customs Pass Guaranteed | Function: | Hormones And Regulation |
High Light: | muscle building sarms,raw sarm powder |
Pharmaceutical SARMS Human Growth SR 9009 Stenabolic CAS 1379686-30-2 For Bodybuilding
Basic Details:
Product Name: SR9009
Synonyms: Stenabolic
CAS: 1379686-30-2
MF: C20H24ClN3O4S
MW: 437.94
Appearance: White powder
Solubility: DMSO
Standard: USP
Application: increase exercise endurance and loss weight
Description:
SR9009, which is currently under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice. Treated mice become lean, develop larger muscles and can run much longer distances simply by taking SR9009, which mimics the effects of aerobic exercise. If similar effects can be obtained in people, the reversal of obesity, metabolic syndrome, and perhaps Type-II diabetes might be the very welcome result.
Dosage:
Dosages of 20-100mg a day have been reported by users without any negative side effects. From the information we have received, results from SR9009 treatment appear to be dose dependent up to a maximum dosage of 100mg per day. After this dosage, results tend to taper off.
What is SR9009 ?
Also known as Stenabolic, SR9009 has been developed by Scripps Research Institute under the leadership of professor Thomas Burris.
As mentioned beforehand, SR9009 is a synthetic Rev-Erb ligand, which is taken orally. This is a very unique compound. By stimulating the Rev-Erb protein, SR9009 has the ability to greatly influence a lot of regulatory mechanisms in the human body. For instance, it can affect the circadian rhythms, lipid and glucose metabolism, fat-storing cells, as well as macrophages. Hence, Stenabolic will allow the user to lose fat and drastically increase endurance, both of which are very desirable effects for an athlete.
Medical Use:
Logically, with so many positive effects, SR9009 will have an extremely varied use in medicine. For instance, the drastic decrease in triglycerides and plasma glucose will be a huge help in the treatment of type 2 diabetes. What's more, Stenabolic will be a crucial element in the treatment of sarcopenia - muscle and strength loss caused by aging.
Additionally, SR9009 will allow doctors to treat obesity in those who for medical reasons cannot train or carry out any exercises, as it can replace exercise. Finally, it is very hard to overestimate its effectiveness in the treatment of cholesterol related conditions or metabolic syndromes.
Use In Bodybuilding:
There is no need to be a genius to realize all the possibilities SR9009 opens to an athlete - amazing endurance and strength, fat loss, muscle hypertrophy (growth), improved cholesterol and blood sugar levels, and an increased metabolism. Hence, one can expect results similar to those seen with Cardarine (GW-501516), but with considerably more extra benefits. Besides, since stenabolic works great both solo or stacked, it will be a very good addition to any steroid or SARMS cycle, and it will give especially impressive results when used together with Cardarine.
All in all, Stenabolic will allow you to do more cardio training, lift more, lose fat, gain lean muscle mass, and improve cholesterol levels. Cholesterol and cardio management is very important when using SR in combination with such steroids.
Other Products:
Name | CAS NO. | Usage |
AICAR | 2627-69-2 | acts by entering nucleoside pools, significantly increasing levels of adenosine |
during periods of ATP breakdown | ||
MK2866 | 841205-47-8 | medical prescription for prevention of cachexia, atrophy, and sarcopenia and |
for Hormone or Testoserone Replacement Therapy. | ||
MK-677 | 15972-10-0 | A hormone secretagogue, treatment of obesity, a promising therapy |
for the treatment of frailty in the elderly | ||
LGD-4033 | 1165910-22-4 | pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 |
GW1516 | 317318-70-0 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
Andarine(S4) | 401900-40-0 | partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
SR9009 | 1379686-30-2 | under development at The Scripps Research Institute (TSRI), |
increases the level of metabolic activity in skeletal muscles of mice | ||
RAD140 | 1182367-47-0 | New generation for gaining mass and cutting edges |
YK11 | 431579-34-9 | YK11: a SARM and myostatin inhibitor in one |